MedPath

Phase II study of S-1 combined with irinotecan in patients with advanced colorectal cancer

Not Applicable
Conditions
Advanced colorectal cancer
Registration Number
JPRN-UMIN000001741
Lead Sponsor
Showa University School of Medicin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1)prior chemotherapy received for advanced disease; 2)other severe medical conditions; 3)other active malignancies;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath